Altamira Therapeutics Ltd. Net Foreign Exchange Gain
Altamira Therapeutics Ltd. (CYTOF) reported Net Foreign Exchange Gain of $1.65 million for the 6-month period ending 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Income Statement › Other Income
ifrs-full:NetForeignExchangeGain · last filed 2025-08-29
CHF
| Period end | Net Foreign Exchange Gain 6 month | Net Foreign Exchange Gain 12 month |
|---|---|---|
| 2022-12-31 | 745.26K CHF 20-F · filed 2023-05-16 | |
| 2022-06-30 | 58.29K CHF 6-K · filed 2023-09-12 | |
| 2021-12-31 | 1.46M CHF 20-F · filed 2023-05-16 | |
| 2021-12-24 | 47.16K CHF 20-F/A · filed 2024-04-22 | |
| 2020-12-31 | 3.21M CHF 20-F · filed 2023-05-16 | |
| 2019-12-31 | 1.34M CHF 20-F · filed 2022-04-12 | |
| 2018-12-31 | 1.10M CHF 20-F · filed 2021-03-31 | |
| 2017-12-31 | 1.91M CHF 20-F · filed 2020-04-16 | |
| 2016-12-31 | 843.95K CHF 20-F · filed 2019-03-14 | |
| 2015-12-31 | 1.81M CHF 20-F · filed 2018-03-22 |
USD
| Period end | Net Foreign Exchange Gain 6 month |
|---|---|
| 2025-06-30 | $1.65M 6-K · filed 2025-08-29 |